Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 297

1.

Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.

Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, Wang XW.

Gastroenterology. 2012 Apr;142(4):957-966.e12. doi: 10.1053/j.gastro.2011.12.039. Epub 2011 Dec 24.

PMID:
22202459
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma.

Liu M, Li Y, Chen L, Chan TH, Song Y, Fu L, Zeng TT, Dai YD, Zhu YH, Li Y, Chen J, Yuan YF, Guan XY.

Gastroenterology. 2014 Apr;146(4):1084-96. doi: 10.1053/j.gastro.2013.12.041. Epub 2014 Jan 11.

PMID:
24417816
[PubMed - indexed for MEDLINE]
3.

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Zimonjic DB, Popescu NC.

Int J Oncol. 2012 Aug;41(2):393-406. doi: 10.3892/ijo.2012.1474. Epub 2012 May 10. Review.

PMID:
22580498
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X.

Carcinogenesis. 2005 Dec;26(12):2050-7. Epub 2005 Jul 6.

PMID:
16000397
[PubMed - indexed for MEDLINE]
Free Article
5.

Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma.

Matsumura S, Imoto I, Kozaki K, Matsui T, Muramatsu T, Furuta M, Tanaka S, Sakamoto M, Arii S, Inazawa J.

Clin Cancer Res. 2012 Jul 1;18(13):3541-51. doi: 10.1158/1078-0432.CCR-11-1007. Epub 2012 May 9.

PMID:
22573353
[PubMed - indexed for MEDLINE]
Free Article
6.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

PMID:
22028922
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.

Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW.

Gastroenterology. 2013 May;144(5):1066-1075.e1. doi: 10.1053/j.gastro.2013.01.054. Epub 2013 Jan 31.

PMID:
23376425
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.

Kwon SM, Kim DS, Won NH, Park SJ, Chwae YJ, Kang HC, Lee SH, Baik EJ, Thorgeirsson SS, Woo HG.

Carcinogenesis. 2013 Jul;34(7):1543-50. doi: 10.1093/carcin/bgt095. Epub 2013 Mar 18. Erratum in: Carcinogenesis. 2013 Nov;34(11):2682.

PMID:
23508637
[PubMed - indexed for MEDLINE]
Free Article
9.

Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.

Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z, Le X, Wei D, Huang S, Xie K.

Gastroenterology. 2012 Sep;143(3):799-810.e1-2. doi: 10.1053/j.gastro.2012.05.043. Epub 2012 Jun 4.

PMID:
22677193
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.

Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY.

World J Gastroenterol. 2014 Jan 7;20(1):183-92. doi: 10.3748/wjg.v20.i1.183.

PMID:
24415871
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma.

Lei KF, Wang YF, Zhu XQ, Lu PC, Sun BS, Jia HL, Ren N, Ye QH, Sun HC, Wang L, Tang ZY, Qin LX.

BMC Cancer. 2007 Sep 4;7:172.

PMID:
17784942
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.

Huang GL, Li BK, Zhang MY, Wei RR, Yuan YF, Shi M, Chen XQ, Huang L, Zhang HZ, Liu W, Huang BJ, Li H, Zheng XF, Luo XR, Wang HY.

PLoS One. 2012;7(8):e44061. doi: 10.1371/journal.pone.0044061. Epub 2012 Aug 31.

PMID:
22952874
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer.

Lee SA, Ho C, Roy R, Kosinski C, Patil MA, Tward AD, Fridlyand J, Chen X.

Hepatology. 2008 Apr;47(4):1200-10. doi: 10.1002/hep.22169.

PMID:
18214995
[PubMed - indexed for MEDLINE]
14.

Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.

Ilboudo A, Nault JC, Dubois-Pot-Schneider H, Corlu A, Zucman-Rossi J, Samson M, Le Seyec J.

BMC Cancer. 2014 Jan 6;14:7. doi: 10.1186/1471-2407-14-7.

PMID:
24393405
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.

Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.

J Surg Oncol. 2012 Mar 15;105(4):381-6. doi: 10.1002/jso.22135. Epub 2011 Nov 3.

PMID:
22052684
[PubMed - indexed for MEDLINE]
16.

RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.

Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.

J Gastroenterol Hepatol. 2008 Sep;23(9):1448-58. Epub 2007 Aug 6.

PMID:
17683489
[PubMed - indexed for MEDLINE]
17.

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.

Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.

PMID:
20388846
[PubMed - indexed for MEDLINE]
Free Article
18.

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.

Ko FC, Yeung YS, Wong CM, Chan LK, Poon RT, Ng IO, Yam JW.

Liver Int. 2010 Jan;30(1):139-48. doi: 10.1111/j.1478-3231.2009.02133.x. Epub 2009 Oct 27.

PMID:
19874489
[PubMed - indexed for MEDLINE]
19.

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.

Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS.

J Clin Invest. 2006 Jun;116(6):1582-95. Epub 2006 May 18.

PMID:
16710476
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.

Endo M, Yasui K, Zen Y, Gen Y, Zen K, Tsuji K, Dohi O, Mitsuyoshi H, Tanaka S, Taniwaki M, Nakanuma Y, Arii S, Yoshikawa T.

Liver Int. 2013 Jan;33(1):105-17. doi: 10.1111/liv.12005. Epub 2012 Oct 22.

PMID:
23088494
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk